Abundance Wealth Counselors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.59M Sell
11,429
-13,953
-55% -$1.95M 0.23% 66
2025
Q4
$3.12M Sell
25,382
-969
-4% -$118K 0.53% 29
2025
Q3
$2.92M Sell
26,351
-984
-4% -$112K 0.5% 33
2025
Q2
$3.02M Sell
27,335
-820
-3% -$87.3K 0.57% 30
2025
Q1
$3.14M Buy
28,155
+443
+2% +$45.7K 0.66% 26
2024
Q4
$2.56M Sell
27,712
-174
-0.6% -$15.7K 0.56% 27
2024
Q3
$2.34M Buy
+27,886
New +$2.13M 0.48% 27
2024
Q2
Sell
-26,673
Closed -$1.95M 89
2024
Q1
$1.95M Buy
26,673
+1,084
+4% +$83.4K 0.45% 33
2023
Q4
$2.07M Buy
25,589
+492
+2% +$38.3K 0.54% 32
2023
Q3
$1.88M Buy
+25,097
New +$1.93M 0.54% 30
2023
Q2
Sell
-26,018
Closed -$2.16M 89
2023
Q1
$2.16M Sell
26,018
-1,789
-6% -$148K 0.55% 26
2022
Q4
$2.39M Buy
27,807
+215
+0.8% +$17K 0.65% 23
2022
Q3
$1.7M Buy
27,592
+634
+2% +$40K 0.49% 28
2022
Q2
$1.67M Buy
26,958
+1,225
+5% +$75.8K 0.45% 33
2022
Q1
$1.53M Buy
25,733
+851
+3% +$54.4K 0.42% 39
2021
Q4
$1.81M Buy
+24,882
New +$1.71M 0.46% 27
2021
Q3
Sell
-23,386
Closed -$1.61M 65
2021
Q2
$1.61M Buy
23,386
+8,717
+59% +$582K 0.42% 26
2021
Q1
$948K Buy
14,669
+3,945
+37% +$254K 0.24% 47
2020
Q4
$625K Buy
10,724
+1,054
+11% +$63.6K 0.16% 61
2020
Q3
$611K Buy
9,670
+3,965
+70% +$275K 0.18% 57
2020
Q2
$439K Buy
+5,705
New +$437K 0.13% 65

Other funds holding GILD

Abundance Wealth Counselors's GILD Position: Q1 2026 in Review

Abundance Wealth Counselors reduced its Gilead Sciences (GILD) stake by 55% in Q1 2026, selling an estimated $1.95M and leaving 11,429 shares worth $1.59M. The position accounts for 0.23% of the portfolio, ranked #66.

Abundance Wealth Counselors first reported a position in GILD in Q2 2020 and has held it in 21 quarters since. The position peaked at $3.14M in Q1 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Abundance Wealth Counselors held 11,429 shares of Gilead Sciences worth $1.59M as of Q1 2026.
  • Abundance Wealth Counselors sold 13,953 Gilead Sciences shares in Q1 2026, an estimated $1.95M.
  • Gilead Sciences made up 0.23% of Abundance Wealth Counselors's portfolio in Q1 2026, its #66 holding.
  • Abundance Wealth Counselors first reported a position in Gilead Sciences in Q2 2020 and has held it in 21 quarters since.
  • Abundance Wealth Counselors's Gilead Sciences position peaked at $3.14M in Q1 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Abundance Wealth Counselors's 13F filing for Q1 2026, filed 23 Apr 2026.